Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality.

PubWeight™: 1.85‹?› | Rank: Top 3%

🔗 View Article (PMID 19841303)

Published in Circulation on October 19, 2009

Authors

Marcello Tonelli1, Gary Curhan, Marc Pfeffer, Frank Sacks, Ravi Thadhani, Michal L Melamed, Natasha Wiebe, Paul Muntner

Author Affiliations

1: Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. mtonelli-admin@med.ualberta.ca

Articles citing this

Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. J Am Soc Nephrol (2011) 2.59

Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res (2011) 2.56

An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. Br J Cancer (2011) 2.21

The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study. Br J Cancer (2010) 1.73

Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons. AIDS (2011) 1.57

An association between time-varying serum alkaline phosphatase concentrations and mortality rate in patients undergoing peritoneal dialysis: a five-year cohort study. Sci Rep (2017) 1.39

Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization. Clin J Am Soc Nephrol (2010) 1.35

Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD. Nephrol Dial Transplant (2010) 1.19

Sodium-dependent phosphate cotransporters and phosphate-induced calcification of vascular smooth muscle cells: redundant roles for PiT-1 and PiT-2. Arterioscler Thromb Vasc Biol (2013) 1.04

Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis. Perit Dial Int (2014) 1.00

Mechanisms of vascular calcification in CKD-evidence for premature ageing? Nat Rev Nephrol (2013) 0.98

The SLC34 family of sodium-dependent phosphate transporters. Pflugers Arch (2013) 0.96

Alkaline phosphatase and mortality in patients on peritoneal dialysis. Clin J Am Soc Nephrol (2014) 0.95

Associations of serum skeletal alkaline phosphatase with elevated C-reactive protein and mortality. Clin J Am Soc Nephrol (2012) 0.94

Cardiovascular risk factors in chronic kidney disease: does phosphate qualify? Kidney Int Suppl (2011) 0.94

Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population. Am J Kidney Dis (2013) 0.93

Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation. Clin J Am Soc Nephrol (2013) 0.93

Impact of age on survival predictability of bone turnover markers in hemodialysis patients. Nephrol Dial Transplant (2013) 0.89

Congestive heart failure: where homeostasis begets dyshomeostasis. J Cardiovasc Pharmacol (2010) 0.88

Biochemical markers of aging for longitudinal studies in humans. Epidemiol Rev (2013) 0.87

Combined alkaline phosphatase and phosphorus levels as a predictor of mortality in maintenance hemodialysis patients. Medicine (Baltimore) (2014) 0.85

Increased serum alkaline phosphatase and serum phosphate as predictors of mortality after stroke. J Clin Diagn Res (2014) 0.85

Cellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its Comorbidities. Front Immunol (2015) 0.84

In Acute Myocardial Infarction Liver Parameters Are Associated With Stenosis Diameter. Medicine (Baltimore) (2016) 0.84

Serum phosphorus and mortality in the Third National Health and Nutrition Examination Survey (NHANES III): effect modification by fasting. Am J Kidney Dis (2014) 0.84

Association between alkaline phosphatase and hypertension in a rural Japanese population: the Nagasaki Islands study. J Physiol Anthropol (2013) 0.83

FGF-23 is associated with increased disease severity and early mortality in cardiogenic shock. Eur Heart J Acute Cardiovasc Care (2013) 0.83

Serum Alkaline Phosphatase and Risk of Incident Cardiovascular Disease: Interrelationship with High Sensitivity C-Reactive Protein. PLoS One (2015) 0.82

A study of relationships between bone-related vitamins and minerals, related risk markers, and subsequent mortality in older British people: the National Diet and Nutrition Survey of People Aged 65 Years and Over. Osteoporos Int (2011) 0.82

Serum 25-hydroxyvitamin D, calcium, phosphorus, and electrocardiographic QT interval duration: findings from NHANES III and ARIC. J Clin Endocrinol Metab (2011) 0.81

Genome-wide association study on serum alkaline phosphatase levels in a Chinese population. BMC Genomics (2013) 0.81

Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study. Endocrine (2016) 0.80

Association between Serum Alkaline Phosphatase Level and Cerebral Small Vessel Disease. PLoS One (2015) 0.80

Loss of PiT-1 results in abnormal endocytosis in the yolk sac visceral endoderm. Mech Dev (2014) 0.79

Aspartate aminotransferase - risk marker for type-2 diabetes mellitus or red herring? Front Endocrinol (Lausanne) (2014) 0.77

Bone mineral metabolism parameters and urinary albumin excretion in a representative US population sample. PLoS One (2014) 0.77

Can serum levels of alkaline phosphatase and phosphate predict cardiovascular diseases and total mortality in individuals with preserved renal function? A systemic review and meta-analysis. PLoS One (2014) 0.76

Association between circulating CD34-positive cells and serum alkaline phosphatase in relation to body mass index for elderly Japanese men. J Physiol Anthropol (2016) 0.75

Prognostic impact of alkaline phosphatase measured at time of presentation in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. PLoS One (2017) 0.75

Plasma alkaline phosphatase and survival in diabetic patients with acute myocardial infarction. Ann Transl Med (2016) 0.75

Joint Effect of Hypertension and Elevated Serum Phosphorus on the Risk of Mortality in National Health and Nutrition Examination Survey-III. J Am Heart Assoc (2015) 0.75

Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho. Bone (2016) 0.75

Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD. Nat Rev Nephrol (2017) 0.75

High Serum Phosphorus Level Is Associated with Left Ventricular Diastolic Dysfunction in Peritoneal Dialysis Patients. PLoS One (2016) 0.75

Does PTH offer additive value to ALP measurement in assessing CKD-MBD? Perit Dial Int (2014) 0.75

High Serum Alkaline Phosphatase, Hypercalcaemia, Race, and Mortality in South African Maintenance Haemodialysis Patients. Int J Nephrol (2017) 0.75

Subclinical change of liver function could also provide a clue on prognosis for patients with spontaneous intracerebral hemorrhage. Neurol Sci (2016) 0.75

Articles by these authors

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Global burden of hypertension: analysis of worldwide data. Lancet (2005) 32.76

Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation (2003) 15.79

Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med (2004) 14.00

Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation (2006) 11.65

Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med (2009) 11.49

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14

The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med (2008) 9.95

Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med (2013) 9.87

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med (2008) 9.19

Mortality prediction with a single general self-rated health question. A meta-analysis. J Gen Intern Med (2005) 8.95

Relation between kidney function, proteinuria, and adverse outcomes. JAMA (2010) 8.26

Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int (2002) 8.03

The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med (2006) 7.06

Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med (2004) 6.53

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med (2003) 6.41

Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol (2006) 6.21

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA (2011) 6.10

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension (2003) 6.01

Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation (2009) 5.82

Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47

The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med (2004) 5.45

Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA (2003) 5.33

Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation (2005) 5.29

Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med (2007) 5.26

Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med (2004) 4.72

Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol (2005) 4.44

Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med (2009) 4.35

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. Clin Infect Dis (2010) 4.28

Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet (2012) 4.25

Prevalence, awareness, treatment, and control of hypertension in china. Hypertension (2002) 4.18

Alcohol intake and risk of incident gout in men: a prospective study. Lancet (2004) 4.12

Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol (2008) 3.82

Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med (2002) 3.77

Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease. Circulation (2008) 3.76

New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care (2009) 3.73

Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ (2008) 3.71

Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics (2009) 3.62

Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study. Ann Intern Med (2011) 3.49

Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol (2002) 3.48

Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. Circulation (2006) 3.47

Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol (2009) 3.40

Independent impact of gout on mortality and risk for coronary heart disease. Circulation (2007) 3.39

Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics (2010) 3.39

Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol (2008) 3.26

Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation (2009) 3.23

Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines. Ann Pharmacother (2008) 3.20

Habitual intake of flavonoid subclasses and incident hypertension in adults. Am J Clin Nutr (2010) 3.19

Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04

Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol (2008) 2.96

Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA (2002) 2.96

Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet (2010) 2.95

Effects of phosphate binders in moderate CKD. J Am Soc Nephrol (2012) 2.92

Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol (2004) 2.91

Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med (2007) 2.89

Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 2.87

Alcohol intake and risk of incident psoriasis in US women: a prospective study. Arch Dermatol (2010) 2.86

Blood pressure measurement device, number and timing of visits, and intra-individual visit-to-visit variability of blood pressure. J Clin Hypertens (Greenwich) (2012) 2.85

Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ (2006) 2.85

Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol (2006) 2.84

Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort. Hypertension (2013) 2.83

Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med (2005) 2.80

Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension (2007) 2.77

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76

Urinary placental growth factor and risk of preeclampsia. JAMA (2005) 2.76

CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70

Statin use and sepsis events [corrected] in patients with chronic kidney disease. JAMA (2007) 2.69

Physician awareness of drug cost: a systematic review. PLoS Med (2007) 2.63

Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care (2009) 2.58

Overview of the Alberta Kidney Disease Network. BMC Nephrol (2009) 2.58

Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res (2011) 2.55

Association of waist circumference and body mass index with all-cause mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis (2011) 2.49

Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2012) 2.49

A meta-analysis of randomized controlled trials evaluating the efficacy of epinephrine for the treatment of acute viral bronchiolitis. Arch Pediatr Adolesc Med (2003) 2.47

Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int (2005) 2.43

Rates of treated and untreated kidney failure in older vs younger adults. JAMA (2012) 2.43

Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study. Ann Intern Med (2015) 2.42

Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States. Am J Med (2004) 2.42

Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease. Am Heart J (2012) 2.42

Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis. CMAJ (2011) 2.40

Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults. Diabetes Care (2010) 2.38

Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. Clin Infect Dis (2009) 2.34

Association between LDL-C and risk of myocardial infarction in CKD. J Am Soc Nephrol (2013) 2.34

Prospective evaluation of analgesic use and risk of renal cell cancer. Arch Intern Med (2011) 2.34

Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol (2008) 2.32

Missed dialysis sessions and hospitalization in hemodialysis patients after Hurricane Katrina. Kidney Int (2009) 2.31

Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the Heart and Soul Study. Am J Epidemiol (2014) 2.30

The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis (2002) 2.26